PL406228A1 - Enzym lakaza wyizolowany z grzyba Cerrena unicolor do zastosowania w leczeniu chorób nowotworowych krwi - Google Patents
Enzym lakaza wyizolowany z grzyba Cerrena unicolor do zastosowania w leczeniu chorób nowotworowych krwiInfo
- Publication number
- PL406228A1 PL406228A1 PL406228A PL40622813A PL406228A1 PL 406228 A1 PL406228 A1 PL 406228A1 PL 406228 A PL406228 A PL 406228A PL 40622813 A PL40622813 A PL 40622813A PL 406228 A1 PL406228 A1 PL 406228A1
- Authority
- PL
- Poland
- Prior art keywords
- fungus
- treatments
- neoplastic diseases
- laccase enzyme
- enzyme isolated
- Prior art date
Links
- 241000293770 Cerrena unicolor Species 0.000 title abstract 2
- 108010029541 Laccase Proteins 0.000 title abstract 2
- 238000011282 treatment Methods 0.000 title abstract 2
- 239000008280 blood Substances 0.000 title 1
- 210000004369 blood Anatomy 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000001613 neoplastic effect Effects 0.000 title 1
- 201000005787 hematologic cancer Diseases 0.000 abstract 1
- 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 abstract 1
Landscapes
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Przedmiotem wynalazku jest enzym lakaza wyizolowany z grzyba Cerrena unicolor, do zastosowania w leczeniu chorób nowotworowych krwi.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL406228A PL225934B1 (pl) | 2013-11-25 | 2013-11-25 | Enzym lakaza wyizolowany z grzyba Cerrena unicolor do zastosowania w leczeniu chorob nowotworowych krwi |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL406228A PL225934B1 (pl) | 2013-11-25 | 2013-11-25 | Enzym lakaza wyizolowany z grzyba Cerrena unicolor do zastosowania w leczeniu chorob nowotworowych krwi |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL406228A1 true PL406228A1 (pl) | 2015-06-08 |
| PL225934B1 PL225934B1 (pl) | 2017-06-30 |
Family
ID=53269063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL406228A PL225934B1 (pl) | 2013-11-25 | 2013-11-25 | Enzym lakaza wyizolowany z grzyba Cerrena unicolor do zastosowania w leczeniu chorob nowotworowych krwi |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL225934B1 (pl) |
-
2013
- 2013-11-25 PL PL406228A patent/PL225934B1/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL225934B1 (pl) | 2017-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JOP20200192A1 (ar) | أجسام مضادة لـ tigit | |
| SA519401522B1 (ar) | Lag-3 أجـسـام مـضـادة لـ وتـركـيـبـات | |
| EA202091540A1 (ru) | Антитела к lilrb2 | |
| CL2015002807A1 (es) | Terapia de combinación | |
| EA201690206A1 (ru) | Терапевтически активные соединения и способы их применения | |
| EA201991214A1 (ru) | Антитела против pd-1 и их композиции | |
| MX2018006831A (es) | Metodos de tratamiento de neoplasias malignas. | |
| CA2919397C (en) | Aryl ethers as hif-2.alpha. inhibitors for the treatment of cancer | |
| EA201400178A1 (ru) | Лечение рака молочной железы | |
| TR201808169T3 (tr) | Rekombinant probiyotik bakteriler . | |
| SV2017005355A (es) | Composiciones de portador-anticuerpo y métodos para realizarlas y utilizarlas | |
| MX373789B (es) | Derivados de piridinil quinolinona como inhibidores de isocitrato deshidrogenasa mutante (mt-idh). | |
| CL2016001082A1 (es) | Proceso para la síntesis de un inhibidor de indolamina 2,3-dioxigenasa | |
| MX373103B (es) | Ciclopropilaminas como inhibidores de desmetilasa específica de lisina 1 (lsd1). | |
| EA201290901A1 (ru) | Фитоканнабиноиды для лечения злокачественной опухоли | |
| BR112015023797A2 (pt) | proteínas de ligação de especificidade dupla dirigidas contra il-1b e/ou il-17 | |
| EA201890961A1 (ru) | Комбинированная терапия для лечения злокачественных новообразований | |
| GEAP202114132A (en) | Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer | |
| EA201691824A1 (ru) | АНТИТЕЛА ПРОТИВ EGFRvIII И ИХ ПРИМЕНЕНИЯ | |
| EA201500314A1 (ru) | Лекарственные формы энзалутамида | |
| MX2012009030A (es) | Identificacion de mutacion lkb1 como biomarcador predictivo para sensibilidad a inhibidores de tor cinasa. | |
| MX377729B (es) | Métodos para tratamiento del melanoma. | |
| WO2015009726A3 (en) | Medical uses of cd38 agonists | |
| EA201791516A1 (ru) | Способы комбинированного лечения злокачественных опухолей | |
| BR112016004095A2 (pt) | administração de enzimas de empobrecimento de quinurenina para a terapia contra tumores |